Loading chat...
NY A10521
Bill
Status
3/6/2026
Primary Sponsor
Andrew Hevesi
Click for details
AI Summary
-
Adds five rare genetic diseases to New York's mandatory newborn screening panel: CLN2 (late-infantile neuronal ceroid lipofuscinosis type 2), MPS IVA, MPS VI, MPS VII, and Fabry disease
-
Amends Public Health Law section 2500-a by adding new paragraphs (l) through (p) to the existing list of required screenings
-
All five conditions are lysosomal storage disorders, which are progressive genetic diseases that can benefit from early detection and treatment
-
Takes effect immediately upon passage
-
Introduced by Assembly Member Hevesi and referred to the Committee on Health
Legislative Description
Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state.
Last Action
referred to health
3/6/2026